Kwon H.L. Triche E. Belanger K. et al.

The epidemiology of asthma during pregnancy : Prevalence, diagnosis, and symptoms.

Immunol Allergy Clin North Am. 26: 29-62Hansen C. Joski P. Freiman H. et al.

Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.

Matern Child Health J. 17: 1611-1621Williamson G. O'Connor A. Kayleigh E.

Women's experiences of personlised support for asthma care during pregnancy: a systematic review of the literature.

BMC Pregnancy Childbirth. 17: 69Grzeskowia L.E. Smith B. Roy A. et al.

Patterns,predictors and outcomes of asthma control and exacerbations during pregnancy: a prospective cohort study.

Eur Respir J. 18: 00054-2015Bokem M.P. Robijn A.L. Jensen M.E. et al.

Factors associated with asthma exacerbations during pregnancy.

J Allergy Cin Immunol Pract. 9: 4343-4352Stevens D.R. Perkins N. Chen Z. et al.

Determining the clinical course of asthma in pregnancy.

J Allergy Cin Immunol Pract. 21: 01125-01129Ali Z. Nilas L. Ulrik C.S.

Postpartum airway responsiveness and exacerbation of asthm during pregnancy-a pilot study.

J Asthma Allergy. 10: 261-267Juniper E. Daniel E. Roberts R. et al.

Improvement in airway hyperresponsiveness and asthma severity during pregnancy. a prospective study.

Am Rev Respir Dis. 140: 924-931Murphy V.E. Gibson P.G. Giles W.B. et al.

Maternal asthma is associated with reduced female fetal growth.

Am J Respir Crit Care Med. 168: 1317-1323Firoozi F. Ducharme F.M. Lemiere C. et al.

Effect of fetal gender on maternal asthma exacerbations in pregnant asthmatic women.

Respir Med. 103: 144-151Bakhireva L.N. SChatz M. Jones K.L. et al.

Fetal sex and maternal asthma control in pregnancy.

J Asthma. 45: 403-407Tan K.S. McFarlane L.C. Lipworth B.J.

Paradoxical down-regulation and desensitization of beta2-adrenoceptors by exogenous progesterone in female asthmatics.

Chest. 111: 847-851Murphy V.E. Gibson P.G. Smith R. et al.

Asthma during pregnancy: mechanisms and treatment implications.

Eur Respir J. 25: 731-750Forbes R.L. Gibson P.G. Murphy V.E. et al.

Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma.

Thorax. 67: 209-214Forbes R.L. Wark P.A. Murphy V.E. et al.

Pregnant women have attenuated innate interferon responses to the 2009 pandemic influenza A virus subtype H1N1.

J Infect Dis. 206: 646-653Murphy V. Namazy J. Powell H. et al.

A meta-analysis of adverse perinatal outcomes in women with asthma.

Br J Obstet Gynaecol. 118: 1314-1323Rejno G. lundholm C. Larsson K. et al.

Adverse pregnancy outcomes in asthmatic women: a population=based family design study.

J Allergy Cin Immunol Pract. 6: 916-922Yland J. Bateman B. Huybrecht K. et al.

Perinatal outcomes associated with maternal asthma and its severity and control during pregnancy.

J Allergy Clin Immunol In Pract. 8 : 1928-1937.e3Rudra C.B. Williams M.A. Frederick I.O. et al.

Maternal asthma and risk of preeclampsia: a case-control study.

J Reprod Med. 51: 94-100Murphy V.E. Clifton V.L. Gibson P.G.

Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes.

Thorax. 61: 169-176Namazy J. Murphy V. Powell H. et al.

Effects of asthma severity,exacerbations and oral corticosteroids on perinatal outcomes.

Eur Respir J. 41: 1082-1090Tata L.J. Lewis S.A. McKeever T.M. et al.

A comprehensive analysis of adverse obstetric and pediatric complications in women with asthma.

Am J Respir Crit Care Med. 175: 991-997Stenius-Aarniala B.S. Hedman J. Teramo K.A.

Acute asthma during pregnancy.

Thorax. 51: 411-414

Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women.

J Allergy Clin Immunol. 121: 1379-1384Murphy V.E. Gibson P. Talbot P.I. et al.

Severe asthma exacerbations during pregnancy.

Obstet Gynecol. 106: 1046-1054Jana N. Vasishta K. Saha S.C. et al.

Effect of bronchial asthma on the course of pregnancy, labour and perinatal outcome.

J Obstet Gynaecol (Tokyo 1995. 21: 227-232Greenberger P.A. Patterson R.

The outcome of pregnancy complicated by severe asthma.

Allergy Proc. 9: 539-543Dombrowski M.P. Schatz M. Wise R. et al.

Asthma during pregnancy.

Obstet Gynecol. 103: 5-12Breton M.-C. Beauchesne M.-F. Lemiere C. et al.

Risk of perinatal mortality associated with asthma during pregnancy.

Thorax. 64: 101-106Breton M. Beauchesne M.F. Lemiere C. et al.

Risk of perinatal mortality associated with asthma durng pregnancy: 2-stage sampling cohort study.

Ann Allergy Asthma Immunol. 105: 211-217Kim S. Kim J. Park S.Y. et al.

Effect of pregnancy in asthma on health care use and perinatal outcomes.

J Allergy Clin Immunol. 136: 1215-1223Cohen J M. Bateman B.T. Huybrechts K.F. et al.

Poorly controlled asthma during pregnancy remains common in the united states.

J Allergy Clin Immunology-In Pract. 7: 2672-2680Firoozi F. Lemiere C. Ducharme F.M. et al.

Effect of maternal moderate to severe asthma on perinatal outcomes.

Respir Med. 104: 1278-1287Triche E.W. Saftlas A.F. Belanger K. et al.

Association of asthma diagnosis, severity, symptoms, and treatment with risk of preeclampsia.

Obstet Gynecol. 104: 585-593Schatz M. Dombrowski M.P. Wise R. et al.

Spirometry is related to perinatal outcomes in pregnant women with asthma.

Am J Obstet Gynecol. 194: 120-126Mirzakhani H. Carey V.J. McElrath T.F. et al.

The association of maternal asthma and early pregnnacy vitamin D with risk of Preeclampsia: an observation fro viatmin D antenatal asthma reduction trial.

J Allergy Cin Immunol Pract. 6: 600-608Eszes N. Toldi G. Bohacs A. et al.

Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy.

PLoS One. 15Dombai B. Ivancso I. Bikov A. et al.

Circulating clusterin and osteopontin levels in asthma and asthmatic pregnancy.

Can Respir J. 2017: 1602039Tamasi L. Somoskovi A. Muller V. et al.

A population-based case-control study on the effect of bronchial asthma during pregnancy for congenital abnormalities of the offspring.

J Asthma. 43: 81-86Powell H. Murphy V.E. Taylor D.R. et al.

Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial.

Lancet. 378: 983-990Palmsten K. Schatz M. Chan P.H. et al.

Validation of the Pregnancy Asthma Control Test.

J Allergy Clin Immunol. 4 (): 310-315.e1Amaral L. Martins C. Coimbra A.

Use of the control of allergic rhinitis and asthma test and pulmonary function tests to assess asthma control in pregnancy.

Aust N Z J Obstet Gynaecol. 58: 1-5Meakin A.S. Saif Z. Seedat N. et al.

The impact of maternal asthma during pregnancy on fetal growth and development: a review.

Expert Rev Resp Med. 14: 1207-1216Rejno G. Lundholm C. Oberg S. et al.

Maternal anxiety,depression and asthma and adverse pregnancy outcomes - a population based study.

Sci Rep. 9: 13101L Blais Ahmed S.I.S. Beauchesne M.F. et al.

Risk of postpartum depression among women with asthma.

J Allergy Cin Immunol Pract. 7: 925-933Grzeskowiak L.E. Smith B. Roy A.

Impact of a history of maternal depression and anxiety on asthma control during pregnancy.

J Asthma. 54: 706-713Lim A.S. Stewart K. Abramson M.J. et al.

Multidisciplinary Approach to Management of MAternal ASthma (MAMMA): a randomized controlled trial.

Chest. 145: 1046-1054Robijn A.L. Jensen M.E. Gibson P.G. et al.

Trends in asthma self-management skills and inhaled corticosteroid use during pregnancy and postpartum from 2004-2017.

J Asthma. 56: 594-602Koo Y.H. Kim Y. Park G.W. et al.

Effect of pregnancy on quantitative medication use and relation to exacerbations in asthma.

Biomed Res Int. 2017: 8276190Sawicki E. Stewart K. Wong S. et al.

Management of asthma by pregnant women attending an Australian maternity hospital.

Aust N Z J Obstet Gynaecol. 52: 183-188Lim A.S. Stewart K. Abramson M.J. et al.

Asthma during pregnancy: the experiences, concerns and views of pregnant women with asthma.

J Asthma. 49: 474-479Robijn A.L. Barker D. Gibson P. et al.

Factors associated with nonadherence to inhaled corticosteroids for asthma during pregnancy.

J Allergy Cin Immunol Pract. 9: 1242-1252Lim A. Stewart K. Abramson M. et al.

Management of pregnant women with asthma by Australian general practitioners.

BMC Fam Pract. 12: 121Cimbollek S. Plaza V. Quirce S. et al.

Knowledge, attitude and adherence of Spanish healthcare professionals to asthma management recommendations during pregnancy.

Allergol Immunopathol (Madr). 41: 114-120Cydulka R. Emerman C. Schreiber D. et al.

Acute asthma among pregnant women presenting to thw emergency department.

Am J Respir Crit Care Med. 160: 887-892McCallister J. Benninger C. Frey H. et al.

Pregnancy related treatement disparities of acute asthma exacberations in the emergency department.

Respir Med. 105: 1434-1440

Incidence and risk factors for exacerbations of asthma during pregnancy.

J Asthma Allergy. 6: 53-60Hodyl N.A. Stark M.J. Schell W. et al.

Perinatal outcomes following maternal asthma and cigarette smokin during pregnancy.

Eur Respir J. 43: 704-716Fazel N. Kundi M. Kazemzadeh A. et al.

Environmnetal tobacco smoke exposure during pregnancy affects complications and birth outcomes in women with and without asthma.

BMC Pregnancy Childbirth. 20: 314Murphy V.E. Clifton V.L. Gibson P.G.

The effect of cigarette smoking on asthma control during exacerbations in pregnant women.

Thorax. 65: 739-744Grarup P.A. Janner J.H. Ulrik C.S.

Passive smoking is associated with poor asthma control during pregnancy: a prospective study of 500 pregnancies.

PLoS One. 9: e112435Gent J.F. Kezik J.M. Hill M.E.

Asthma medication use during pregnancy, wheeze and estimated exposure to ambient nitrogen dioxide.

Eur Respir J. 45: 538-540Mendola P. Wallace M. Hwang B.S.

Preterm birth and air pollution: critical windows of exposure for women with asthma.

J Allergy Cin Immunol. 138: 432-440Sorri M. Hartikainen A. Karja I.

Rhinitis during pregnancy.

Rhinology. 18: 83-86Munn M. Groome L. Atterbury J.

Pneumonia as a complication of pregnancy.

J Matern Fetal Med. 8: 151-154Cox S. Posner S.F. McPheeters M. et al.

Hospitalizations with respiratory illness among pregnant women during influenza season.

J Obstet Gynecol. 107: 1315-1322Chambers C. Krishnan J.A. Alba L. et al.

The safety of asthma medications during pregnancy and lactation:clinical management and research priorities.

J Allergy Cin Immunol. 147: 2009-2020Schatz M. Dombrowski M.P. Wise R. et al.

The relationship of asthma medication use to perinatal outcomes.

J Allergy Clin Immunol. 113: 1040-1045Schatz M. Zeiger R.S. Harden K. et al.

The safety of asthma and allergy medications during pregnancy.

J Allergy Clin Immunol. 100: 301-306Norjavaara E. de Verdier M.G.

Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide.

J Allergy Clin Immunol. 111: 736-742Bracken M.B. Triche E.W. Belanger K. et al.

Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies.

Obstet Gynecol. 102: 739-752Martel M.J. Rey E. Beauchesne M.F. et al.

Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study.

BMJ. 330: 230Kallen B. Rydhstroem H. Aberg A.

Congenital malformations after the use of inhaled budesonide in early pregnancy.

Obstet Gynecol. 93: 392-395Bakhireva L.N. Jones K.L. Schatz M. et al.

Asthma medication use in pregnancy and fetal growth.

J Allergy Clin Immunol. 116: 503-509Murphy V.E. Jensen J.S. Gibson P.

Asthma during pregnancy: exacerbations, management, and health outcomes for mother and infant.

Semin Respir Crit Care Med. 38: 160-173Park-Wyllie L.M.P. Pastuszak A. et al.

Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiologic studies.

Teratology. 62: 385-392Skuladottir H. Wilcox A.J. Ma C. et al.

Corticosteroid use and risk of orofacial clefts.

Birth Defects Res A Clin Mol Teratol. 100: 499-506Palmsten K. Bandoli G. Watkins J. et al.

Oral corticosteroids and risk of preterm borth in the california medicaid program.

J Allergy Cin Immunol Pract. 9: 375-384Namazy J. Schatz M. Long L. et al.

Use of inhaled steroids by pregnant asthmatic women does not reduce intrauterine growth.

J Allergy Clin Immunol. 113: 427-432Rahimi R. Nikfar S. Abdollahi M.

Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review.

Hum Exp Toxicol. 25: 447-452Charlton R.A. Hutchison A. Davis K.J. et al.

Asthma management in pregnancy. Research Support, Non-U.S. Gov't.

PLoS One. 8: e60247Cossette B. Beauchesne M.F. Forget A. et al.

Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy. Comparative Study Research Support, Non-U.S. Gov't.

Ann Allergy Asthma Immunol. 112: 459-464

Use of sodium cromoglycate during pregnancy: results on 296 asthmatic women.

Acta Therap. 8: 45-51Sarkar M. Koren G. Kalra S. et al.

Montelukast use during pregnancy;a multicentre,prospective,comparative study of infant outcomes.

Eur J Clin Pharmacol. 65: 1259-1264Bakhireva L.N. Jones K.L. Schatz M. et al.

Safety of leukotriene receptor antagonists in pregnancy.

J Allergy Clin Immunol. 119: 618-625Nelsen L.M. Shields K.E. Cunningham M.L. et al.

Congenital malformationsamong infants born to women receiving montelukast, inhlaed corticosteroids, and other asthma medications.

J Allergy Clin Immunol. 129 (): 251-254Cavero-Carbonell C. Vinketl-Hansen A. Rabanque-Hernandez M.J. et al.

Fetal exposure to montelukast and congenital anomalies: a population based study in Denmark.

Birth Defects Original Res. 109: 452-459Namazy J. Cabana M. Scheuerle A. et al.

The Xolair pregnancy registry(EXPECT):An observational study of Omalizumab during pregnancy in women with asthma.

Am J Respir Crit Care Med. 185: A4221Briggs G.G. Freeman R.K. Towers C.V. et al.

Drugs in pregnancy and lactation : a reference guide to fetal and neonatal risk.

11th edition. Wolters Kluwer, : 1646 ()Munsie JP S.L. Browne M.L. et al.

Maternal bronchodilator use and the risk of orofacial clefts.

Hum Reprod. 26: 3147-3154Lin S. Herdt-Losavio M. Gensburg L. et al.

Maternal, asthma medication use, and the risk of congenital heart defects.

Borth Defects Res A Clin Mol Teratol. 85: 161-168Garne E. Hansen A.V. Morris J. et al.

Use of asthma medicaiton during pregnancy adn risk of specific congenital anomalies:A European case-malformed control study.

J Allergy Clin Immunol. 136: 1496-1502Lin S. Munsie J.P.W. Herdt-Losavio M.L. et al.

Maternal asthma medication use and the risk of selected birth defects.

Pediatrics. 129: e317-e324Heinonen O.P. Slone D. Shapiro S.

Birth defects and drugs in pregnancy Massachusetts:.

Publishing Sciences Group, : 516 ()Wilton L.V. Pearce G.L. Martin R.M. et al.

The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England.

Br J Obstet Gynaecol. 105: 882-889Eltonsy S. Forget A. Blais L.

Beta2-agonists use during pregnancy and the risk of congenital malformations.

Birth Defects Res A Clin Mol Teratol. 91: 937-947Eltonsy S. Forget A. Beauchesne M.F. et al.

Risk of congenital malformations for asthmatic pregnant women using long-acting beta-agonist and inhaled corticosteroid combination versus higher-dose inhlaed corticosteroid monotherapy.

J Allergy Clin Immunol. 135: 123-130Stenius-Aarniala B. Riikonen S. Teramo K.

Slow-release theophylline in pregnant asthmatics.

Chest. 107: 642-647Park J.M. Schmer V. Myers T.L.

Cardiovascular anomalies associated with prenatal exposure to theophylline.

South Med J. 83: 487-488